Shanghai yingli pharmaceutical
WebbShanghai YingLi Pharmaceutical Co. Ltd. 2024-09-30 Phase 1 A Single-Arm, Open-Label, Multi-Center, Phase I Study of YY-20394 in Patients With Recurrent or Refractory Peripheral T-Cell Lymphoma WebbRelying on the abundant Marine resources in Southeast Asia, Yingli Chemical (Shanghai) Co., Ltd. is engaged in the processing and research and development of six series of industrial salt, bromine, bromine inorganic salts, flame retardants, fungicides, cleaning agents, pharmaceutical pesticides and chemical intermediates.In addition, the Shanghai …
Shanghai yingli pharmaceutical
Did you know?
Webb9 feb. 2024 · Shanghai Yingli Pharmaceutical Co Ltd (Yingli Pharma), a small-molecule innovation drug research and development company, formed a new partnership with Jiangsu Hengrui Medicine Co Ltd (Hengrui ... WebbShanghai Yingli Pharmaceutical overview. Shanghai Yingli Pharmaceutical (Yingli) is a pharmaceutical company focused on discovery and development of innovative small …
Webb3 sep. 2024 · Yingli is advancing several early-stage precision therapy programs leading to IND-enabling studies this year. For more information, visit http://www.yl-pharma.com … Webb6 apr. 2024 · YY-20394: Shanghai YingLi Pharmaceutical Co. Ltd. Drug profiles in the detailed report….. Pre-clinical and Discovery Stage Products Drug profiles in the detailed report….. Inactive Products Peripheral T-Cell Lymphomas (PTCL) Key Companies Peripheral T-Cell Lymphomas (PTCL) Key Products Peripheral T-Cell Lymphomas (PTCL)- Unmet …
Webb5 nov. 2024 · Zhiming Li, Haiyan Yang, Hong Cen, Rui Huang, Zhen Cai, Xuekui Gu, Hanying Bao, Zusheng Xu, Zuhong Xu; Single-Arm Phase 1b/2 Trial of the PI3Kδ Inhibitor Linperlisib Combining with Gemox in Relapsed and/or Refractory Diffuse Large B Cell Lymphoma. Webb24 jan. 2024 · No New Molecular Entity Yes Highest Development Phases Phase II Gout; Hyperuricaemia Most Recent Events 24 Jan 2024 YL 90148 is still in phase II clinical trial in Gout and Hyperuricaemia in China (Shanghai Yingli Pharmaceutical pipeline, January 2024) ; 23 Dec 2024 Phase-II clinical trials in Gout in China (PO) (Shanghai Yingli …
Webb4 juni 2024 · Yingli Pharma, headquartered in Shanghai with a subsidiary in San Francisco, is an innovative clinical stage biopharmaceutical company. Yingli Pharma is developing …
Webb4 juni 2024 · Yingli Pharma, headquartered in Shanghai with a subsidiary in San Francisco, is an innovative clinical stage biopharmaceutical company. Yingli Pharma is developing best-in-class and first-in-class oral investigational agents for the treatment of cancer, metabolic and autoimmune diseases. list of minor league baseball ballparksWebb23 aug. 2024 · 4 Shanghai Yingli Pharmaceutical Co., Ltd, Shanghai, China. 5 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 288 Nanjing Road, … imdb stone of destinyWebb24 jan. 2024 · YL 90148 is a new generation uric acid transporter 1 (URAT1; SLC22A12) selective inhibitor, being developed by Shanghai Yingli Pharmaceutical, for the treatment … list of minutemenhttp://www.yl-pharma.com/cn/index.html imdb stranger things s4Webb1 mars 2024 · Shanghai Yingli Pharmaceutical overview. Shanghai Yingli Pharmaceutical (Yingli) is a pharmaceutical company focused on discovery and development of … imdb stream freeWebb11 juni 2024 · Yingli Pharma, headquartered in Shanghai with a subsidiary in San Francisco, is an innovative clinical stage biopharmaceutical company. Yingli Pharma is … list of minor surgery proceduresWebbShanghai Yingli Pharmaceutical Co Ltd is a company that operates in the Pharmaceuticals industry. It employs 6-10 people and has $1M-$5M of revenue. The company is … list of minors georgia tech